Evidence that L-arginine is a key amino acid in sickle cell anemia - A preliminary report

Nutrition Research

Volumn 19, Issue 4, 1999, Pages 501-518

  Waugh, William H ^a   Daeschner III, Charles W ^a   Files, Beatrice A ^a   Gordon, Diana W ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Amino acid; Arginase; Creatinine; Hemoglobin; L arginine; Sickle cell anemia

Indexed keywords

ARGINASE; ARGININE; BILIRUBIN; CREATINE; CREATINE KINASE ISOENZYME; CREATINE PHOSPHATE; CREATININE; ESSENTIAL AMINO ACID; HEMOGLOBIN; NITRIC OXIDE;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE DEFORMABILITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEGRO; PRIORITY JOURNAL; PROTEIN DEFECT; SICKLE CELL ANEMIA; UNITED STATES;

PROTEA;

EID: 0033119962     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(99)00017-2     Document Type: Article

References (65)

1. Bunn H.F. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997;337:762-9.
2. Bunn H.F. Disorders of hemoglobin. In: Isselbacher, KJ, Braunwald, E, Wilson, JD, Martin, JB, Fauci, AS, Kasper, DL, eds. Harrison's Principles of Internal Medicine. Vol. 2. New York:McGraw-Hill, 1994:1734-43.
3. Serjeant G, Serjeant B, Stephens A, Roper D, Higgs D, Beckford M, Cook J, Thomas P. Determinants of haemoglobin level in steady-state homozygous sickle cell disease. Brit J Haematol 1996;92:143-9.
4. Varat MA, Adolph RJ, Fowler NO. Cardiovascular effects of anemia. Am Heart J 1972; 83:415-26.
5. Lonsdorfer J, Bogui P, Otayeck A, Bursauh E, Poyart C, Cabannes R. Cardiorespiratory adjustments in chronic sickle cell anemia. Bull Europ Physiopath Resp 1983;19:339-44.
6. Salman EK, Haymond MW, Bayne E, Sager BK, Wiisamen A, Pitel P, Darmaun D. Protein and energy metabolism in prepubertal children with sickle cell anemia. Pediatr Res 1996;40:34-40.
7. Bessman SP. The justification theory: The essential nature of the non-essential amino acids. Nutr Rev 1979;37:209-20.
8. Castillo L, Ajami A, Branch S, Chapman TE, Yu YM, Burke JF, Young VR. Plasma arginine kinetics in adult man: Response to an arginine free diet. Metab 1994;43:114-22.
9. Enwonwu CO, Xu XU, Turner E. Nitrogen metabolism in sickle cell anemia: Free amino acids in plasma and urine. Am J Med Sc 1990;300:366-71.
10. Vander Jogt DJ, Kanellis GJ, Isichei C, Pastuszyn A, Glew RH. Serum and urinary amino acid levels in sickle cell disease. J Tropical Ped 1997;43:220-5.
11. Visek WJ. Arginine needs, physiological state and usual diets. A reevaluation. J Nutr 1986;116:46-46.
12. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
13. Schmidt HHHW, Walter U. NO at work. Cell 1994;78:919-25.
14. Förstermann U, Closs EI, Pollack JS, Nakane M, Schwarz P, Gath I, Kleinert H. Nitric oxide synthase isozymes. Hypertension 1994;23:1121-31.
15. Arnal JF, Münzel T, Venema RC, James NL, Bai C, Mitch WE, Harrison DG. Interactions between L-arginine and L-glutamine change endothelial no production. J Clin Invest 1995;95:2565-72.
16. Bogle RG, Coade SB, Moncada S, Pearson JD, Mann GE. Bradykinin and ATP stimulate 1-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Commun 1991;180:926-32.
17. McDonald KK, Zharikow S, Block ER, Kilberg MS. A calveolar complex between the cationic amino acid transporter/and endothelial nitric-oxide synthase may explain the "Arginine Paradox". J Biol Chem 1997;272:31213-6.
18. Barbul A. Arginine:biochemistry, physiology, and therapeutic implications. J Parenteral Enteral Nutr 1986;10:227-38.
19. Young VR, El-Khoury AE. Chapter 13. The notion of the nutritional essentiality of amino acid requirements in adults. In: Cynober, LA, ed. Amino Acid Metabolism and Therapy in Health and Nutritional Disease. Boca Raton: CRC Press, 1995;191-252.
20. Staron T, Allard C, Chambre M-N, Xuong N.D. Sur une méthode de dosage de l'arginine et des groupements quanidyles dans les milieux biologiques et dans les protéins. Comp Rendus 1963;257:2552-4.
21. Micklus MJ, Stein IM. Colorimetric determination of mono- and disubstituted guanidines. Anal Biochem 1973;54:545-53.
22. Crosby WH, Furth FW. A modification of the benzidine method for measuring hemoglobin in plasma and urine. Blood 1956;11:380-3.
23. Hare RS. Endogenous creatinine in serum and urine. Proc Soc Exptl Biol Med 1950;74:148-51.
24. Porembska Z, Kedra M. Early diagnosis of myocardial infarction by arginase activity determination. Clin Chim Acta 1975;60:355-61.
25. Levine JM, Leon R, Steigmann F. A rapid method for the determination of urea in blood and urine. Clin Chem 1961;7:488-93.
26. Waugh WH, Beall PT. Simplified measurement of p-aminohippurate and other arylamines in plasma and urine. Kidney Int 1974;5:429-36.
27. Naumann HN, Diggs LW, Barreras L, Williams BJ. Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. Am J Clin Path 1971;56:137-47.
28. Keitel HG, Blakely J. The plasma hemoglobin concentration in sickle-cell disease. J Dis Child 1956;92:511-2.
29. Stutman LJ, Shinowara GY. Plasma tetrapyrrole pigments in sickle cell anemia. Am J Clin Path 1965;43:94-103.
30. Harris JW, Brewster HH, Ham TH, Castle WB. Studies on the destruction of red blood cells X. The biophysics and biology of sickle-cell disease. Arch Intern Med 1956;97:145-68.
31. Repka T, Hebbel RP. Hydroxyl radical formation by sickle erythrocyte membranes: Role of pathologic iron deposits and cytoplasmic reducing agents. Blood 1991;78:2753-8.
32. Malinow MR. Plasma homocyst(e)ine: A risk factor for arterial occlusive diseases. J Nutr 1996;126:1238S-43S.
33. Houston PE, Rana S, Sekhsaria S, Perlin E, Kim KS, Castro OL. Homocysteine in sickle cell disease: Relationship to stroke. Am J Med 1997;103:192-6.
34. Francis RB Jr, Johnson CS. Vascular occlusion in sickle cell disease: Current concepts and unanswered questions. Blood 1991;77:1405-14.
35. Berney SI, Ridler CD, Stephens AD, Thomas AE, Kovacs IB. Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anemia. Am J Hematol 1992;40:290-4.
36. Kanner J, Harel S, Granit R. Nitric oxide as an antioxidant. Archiv Biochem Biophys 1991;289:130-136.
37. Kanner J, Harel S, Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 1992;27:46-9.
38. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-18.
39. DeGroote MA, Testerman T, Xu Y, Stauffer G, Fang FC. Homocysteine antagonism of nitric oxide-related cytostasis in salmonella typhimurium. Science 1996;272:414-7.
40. Martin W, Smith JA, White DG. The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Brit J Pharmac 1986;89:563-71.
41. Melkumyants AM, Balaskov SA, Khayulin VM. Control of arterial lumen by shear stress on endothelium. News Physiol Sci 1995;10:204-10.
42. Hebbel RP, Eaton JW, Balasingam M, Steinberg MH. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 1982;70:1253-9.
43. Rees DC, Cervi P, Grimwade D, et al. The metabolites of nitric oxide in sickle-cell disease. Brit J Haemat. 1995;91:834-7.
44. Sproule BJ, Halden ER, Miller WF. A study of cardiovascular alterations in patients with sickle cell disease and its variants. J Clin Invest 1958;37:486-95.
45. French JA, Kenny D, Scott JP, et al. Mechanisms of stroke in sickle cell disease: Sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition. Blood 1997;89:4891-9.
46. Yosatha RJ, Kashyap S, Trifiletti RR. Arginine deficiency accompanies persistent pulmonary hypertension of the newborn. Biol Neonate 1994;66:65-70.
47. McCaffrey MJ, Bose CL, Reiter PD, Stiles AD. Effect of L-arginine infusion on infants with persistent pulmonary hypertension of the newborn. Biol Neonate 1995;67:240-3.
48. McMahon LEC. In: Case records of the Massachusetts General Hospital. Case 34-1997. New Engl J Med 1997;337:1293-1301.
49. Atz AM, Wessel DL. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 1997;87:988-90.
50. Perry TL, Hansen S. Technical pitfalls leading to errors in the quantitation of plasma amino acids. Clin Chim Acta 1969;25:53-8.
51. Seip M, Lindemann R, Gjesdahl P, Gjeasing LR. Amino acid concentrations in plasma and erythrocytes in aregeneratory and haemolytic anaemias. Scand J Haematol 1975;15:178-86.
52. Greenstein JP, Winitz M. In: Chemistry of the Amino Acids. Vol. 2. New York: Wiley & Sons, 1961:1807-8.
53. Choremis C, Zannos L, Basti B. Amino-aciduria in cooley and sickle cell anaemias. J Clin Path 1957;10:330-5.
54. Jackson AA, Landman JP, Stevens MCG, Sergeant GR. Urea kinetics in adults with homozygous sickle cell disease. Europ J Clin Nutr 1988;491-6.
55. Latner AL. In: Cantarow and Trumper Clinical Biochemistry, 7th Ed. Philadelphia: Saunders, 1975:181.
56. Mehler AH. In: Devlin, TM, ed. Textbook of Biochemistry with Clinical Correlations, 3rd Ed. New York: Wiley-Liss, 1992;518-9.
57. Walliman T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: The 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992;281:21-40.
58. Badaloo A, Jackson AA, Jahoor F. Whole body protein turnover and resting metabolic rate in homozygous sickle cell disease. Clin Sci 1989;77:93-7.
59. Heyman MB, Vichinsky E, Katz R, Gaffield B, Burst D, Castillo R, Chiu D, Kleman K, Ammann AJ, Thaler MJ, Lubin B. Growth retardation in sickle-cell disease treated by nutritional support. Lancet 1985;1:903-6.
60. Windmueller HG, Spaeth AE. Source and fate of circulating citrulline. Am J Physiol 1981;241:E473-80.
61. Noeh FM, Wenzel A, Harris N, Milakofsky L, Hofford JM, Pell S, Vogel WH. The effects of arginine administration on the levels of arginine, other amino acids and related amino compounds in the plasma, heart, aorta, vena cava, bronchi and pancreas of the rat. Life Sciences 1996;58:131-8.
62. Daeschner III CW, Matustik MC, Capentieri U, Haggard ME. Zinc and growth in patients with sickle cell disease. J Pediatrics 1981;98:778-80.
63. Visser JJ, Koekman K. Arginine supplementation in the prevention and treatment of osteoporosis. Med Hypotheses 1994;43:339-42.
64. Kamoun P, Rabier D, Bardet J, Parvy P. Citrulline concentrations in human plasma after arginine load. Clin Chem 1991;37:1287.
65. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cell injury. Proc Natl Acad Sci USA 1996;93:6770-4.